Study Reveals Impact on Utilization and Cost of Point-of-Sale Diagnosis Verification of GLP-1s

A recent Navitus study evaluated an automated point-of-sale diagnosis verification system for GLP-1 medications used in type 2 diabetes. The findings suggest that this approach helped manage growth in GLP-1 utilization and associated costs compared with traditional management methods, while maintaining timely patient access and supporting more efficient medication management.